TNNT2 and cardiovascular disorder: Since patients with stable cardiovascular disease are typically seen at larger scheduled intervals, e.g., 6–12 months in an outpatient department or by an office cardiologist it is tempting to speculate that consideration of hs-cTnT long-term changes beyond biovariability better reflect a disease progression and might, therefore, be a more reliable risk indicator for cardiovascular events.